Patrick Perrigue

Patrick Perrigue


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2016 in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Verified
Journal Article
Closed access
PPPatrick Perrigue
Patrick Perrigue
JNJoseph Najbauer
Joseph Najbauer
JJan Barciszewski
Jan Barciszewski

30 June 2020 in Cancers
Verified
Journal Article
Open access
PDF file
PPPatrick Perrigue
Patrick Perrigue
MRMagdalena Rakoczy
Magdalena Rakoczy
KPKamila P. Pawlicka
Kamila P. Pawlicka
ABAgnieszka Belter
Agnieszka Belter
MGMałgorzata Giel-Pietraszuk
Małgorzata Giel-Pietraszuk
MFMarek Figlerowicz
Marek Figlerowicz
Cellular senescence is a tumor-suppressive mechanism blocking cell proliferation in response to stress. However, recent evidence suggests that senescent tumor cells can re-enter the cell cycle to become cancer stem cells, leading to relapse after cancer chemotherapy treatment. Understanding how the senescence reprogramming process is a precursor to cancer stem cell formation is of great medical importance. To study the interplay between senescence, stemness, and cancer, we applied a stem cell medium (SCM) to human embryonic fibroblasts (MRC5 and WI-38) and cancer cell lines (A549 and 293T). MRC5 and WI-38 cells treated with SCM showed symptoms of oxidative stress and became senescent. Transcriptome analysis over a time course of SCM-induced senescence, revealed a developmental process overlapping with the upregulation of genes for growth arrest and the senescence-associated secretory phenotype (SASP). We demonstrate that histone demethylases jumonji domain-containing protein D3 (Jmjd3) and ubiquitously transcribed tetratricopeptide repeat, X chromosome (Utx), which operate by remodeling chromatin structure, are implicated in the senescence reprogramming process to block stem cell formation in fibroblasts. In contrast, A549 and 293T cells cultured in SCM were converted to cancer stem cells that displayed the phenotype of senescence uncoupled from growth arrest. The direct overexpression of DNA methyltransferases (Dnmt1 and Dnmt3A), ten-eleven translocation methylcytosine dioxygenases (Tet1 and Tet3), Jmjd3, and Utx proteins could activate senescence-associated beta-galactosidase (SA-β-gal) activity in 293T cells, suggesting that epigenetic alteration and chromatin remodeling factors trigger the senescence response. Overall, our study suggests that chromatin machinery controlling senescence reprogramming is significant in cancer stem cell formation.

1 November 2015 in Trends in Biochemical Sciences
Verified
Journal Article
Closed access
PDF file
PPPatrick Perrigue
Patrick Perrigue
VEVolker A. Erdmann
Volker A. Erdmann
JJan Barciszewski
Jan Barciszewski